Surmodics Reports Fourth Quarter and Fiscal Year 2024 Financial Results
Surmodics, Inc. (SRDX)
Last surmodics, inc. earnings: 4/29 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
surmodics.gcs-web.com/investor-overview
Company Research
Source: Business Wire
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its fourth quarter and fiscal year ended September 30, 2024.Fourth Quarter Fiscal 2024 Financial SummaryTotal Revenue of $33.2 million, an increase of 19% year-over-yearTotal Revenue excluding SurVeil™ drug-coated balloon (“DCB”) license fee revenue(1) of $31.3 million, an increase of 17% year-over-yearGAAP net loss of $(3.4) million, compared to net income of $6.7 million in the prior-year periodAdjusted EBITDA(2) of $4.4 million, compared to $1.7 million in the prior-year periodFiscal 2024 Financial SummaryTotal Revenue of $126.1 million, compared to $132.6 million in the prior-year period which included $25.0 million in license fee revenue recognized upon receipt of a $27.0 million milestone payment associated with obtaining FDA premarket approval of the SurVeil DCBTotal R
Show less
Read more
Impact Snapshot
Event Time:
SRDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SRDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SRDX alerts
High impacting Surmodics, Inc. news events
Weekly update
A roundup of the hottest topics
SRDX
News
- Surmodics, Inc. (NASDAQ: SRDX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- SurModics (SRDX) is an Incredible Growth Stock: 3 Reasons Why [Yahoo! Finance]Yahoo! Finance
- Surmodics Q4 Earnings and Revenues Beat Estimates, Margin Down [Yahoo! Finance]Yahoo! Finance
- Surmodics, Inc. (NASDAQ: SRDX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.MarketBeat
- Surmodics, Inc. (NASDAQ: SRDX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
SRDX
Earnings
- 5/1/24 - Beat
SRDX
Sec Filings
- 11/15/24 - Form SCHEDULE
- 11/14/24 - Form SC
- 11/6/24 - Form SC
- SRDX's page on the SEC website